23 May 2013
Keywords: fda, extends, decision, date, requip, xl, 2nd-qtr
Article | 11 February 2008
GlaxoSmithKline and fellow UK-based SkyePharma say that the US Food and Drug Administration has extended its decision date regarding the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 February 2008
© 2013 thepharmaletter.com